コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 nsis, and a fourth Campylobacter species, C. helveticus.
2 bacter: jejuni, coli, lari, upsaliensis, and helveticus.
3 or C. lari and between C. upsaliensis and C. helveticus.
4 at prtH is not broadly distributed within L. helveticus.
5 fermented reconstituted milk (Lactobacillus helveticus, 37 degrees C, 48 h) lower concentrations of
6 he isolates were identified as Campylobacter helveticus, 47% of the isolates were identified as Campy
9 a probiotic mixture containing Lactobacillus helveticus and Lactobacillus rhamnosus was provided 1 we
12 potential pathogens, including Campylobacter helveticus, and because H. canis was isolated from nondi
13 e and proteolytic strains like Lactobacillus helveticus, are added for flavor improvement or accelera
14 o Lactobacillus species, L. hamsteri, and L. helveticus, as indicator species occurring differentiall
16 e 14-amino-acid (aa) auxotroph Lactobacillus helveticus CNRZ32, single- and multiple-peptidase-deleti
17 cillus delbrueckii subsp. lactis DSM7290, L. helveticus CNRZ32, Streptococcus thermophilus CNRZ302, a
21 causing faster and stronger autolysis of L. helveticus DPC 4571 and an increase in L. casei ATCC 334
22 e impact of using LAB strains (Lactobacillus helveticus DPC 4571 and Lactobacillus casei ATCC 334) di
25 ethod, mixed C. lari, C. upsaliensis, and C. helveticus isolates were identified; upon separation, ea
26 terologous overexpression of a Lactobacillus helveticus L-lactate dehydrogenase in M. buryatense resu
27 n yogurts, and the addition of Lactobacillus helveticus LH-B02 favored the formation of peptides reco
30 ri (n = 20), C. upsaliensis (n = 78), and C. helveticus (n = 9) isolates, representing both clinical
31 zae, Saccharomyces cerevisiae, Lactobacillus helveticus) on the immunoreactivity, physicochemical and
33 vities of lactobacillus (L. plantarum and L. helveticus) prepared amaranth protein hydrolysates, to d
34 pants administered a Lactobacillus rhamnosus/helveticus probiotic compared with those administered pl
36 e anxiolytic probiotic strains Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 reduce
37 those administered the L. rhamnosus R0011/L. helveticus R0052 product experienced fewer diarrheal epi
40 ication of the HU protein biomarker for a C. helveticus strain, whose hup gene was not sequenced, but
41 ith peptide production and that Mongolian L. helveticus strains differ from Western strains in terms
42 incorporation of putative probiotic - the L. helveticus, to ferment cream prior to butter production